{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:32:10Z","timestamp":1792740730772,"version":"4.5.0"},"reference-count":101,"publisher":"Informa UK Limited","issue":"6","funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","award":["B197"],"award-info":[{"award-number":["B197"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2018,6,3]]},"DOI":"10.1080\/14760584.2018.1483726","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T18:02:15Z","timestamp":1528480935000},"page":"461-477","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":63,"title":["From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine"],"prefix":"10.1080","volume":"17","author":[{"given":"John L.","family":"Perez","sequence":"first","affiliation":[{"name":"Pfizer Vaccines Research and Development, Collegeville, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Absalon","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Research and Development, Pearl River, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Beeslaar","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Research and Development, Hurley, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Balmer","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Research and Development, Collegeville, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin U.","family":"Jansen","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Research and Development, Pearl River, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Jones","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Research and Development, Pearl River, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Harris","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Research and Development, Pearl River, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"York","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Medical Development, Scientific & Clinical Affairs, Collegeville, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Research and Development, Collegeville, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Radley","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Research and Development, Collegeville, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annaliesa S.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Research and Development, Pearl River, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Crowther","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Research and Development, Hurley, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Eiden","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Research and Development, Pearl River, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70273-7"},{"key":"CIT0002","first-page":"1","volume":"62","author":"Cohn AC","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.3201\/eid1904.111799"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)67932-4"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199611000-00009"},{"key":"CIT0006","unstructured":"Centers for Disease Control and Prevention. Meningococcal disease: technical and clinical information. [cited 2017 Oct 4]. Available from: http:\/\/www.cdc.gov\/meningococcal\/clinical-info.html"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(81)80250-8"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1586\/erv.11.117"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1086\/649209"},{"key":"CIT0010","unstructured":"Menactra\u00ae (MCV4)1. Full Prescribing Information, Sanofi Pasteur Inc. Swiftwater, PA, 2014."},{"key":"CIT0011","unstructured":"Menveo\u00ae (Meningococcal [groups A, C, Y and W-135] oligosaccharide diphtheria CRM197conjugate vaccine). Full Prescribing Information, Novartis Vaccines and Diagnostics, Inc. Sovicille, Italy, 2013."},{"key":"CIT0012","unstructured":"Nimenrix Product Monograph (Meningococcal polysaccharide groups A, C, W-135 and Y conjugate vaccine). Full Prescribing Information, Pfizer Canada Inc, Kirkland, Quebec, 2016."},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90340-9"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.4161\/hv.24129"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603940103"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.4161\/hv.34293"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.10.5.780-786.2003"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.051"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1307"},{"key":"CIT0020","unstructured":"Vaccines and Related Biologic Products Advisory Committee. Approaches to licensure of meningococcal vaccines for prevention of serogroup B invasive meningococcal disease. Briefing document for the Vaccines and Related Biologic Products Advisory Committee Meeting. Apr 7, 2011. [cited 2017 Apr 10]. Available from: http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/BloodVaccinesandOtherBiologics\/VaccinesandRelatedBiologicalProductsAdvisoryCommittee\/UCM248586.pdf"},{"key":"CIT0021","unstructured":"European Medicines Agency. EPAR summary for the public: Trumenba. [cited 2017 Oct 23]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/human\/004051\/WC500228998.pdf"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6441a3"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.4.2088-2100.2004"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.01.075"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021911"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.083"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00056-12"},{"key":"CIT0028","unstructured":"Trumenba\u00ae (meningococcal group B vaccine). Full Prescribing Information, Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc, Philadelphia, PA, 2017."},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2016.1130628"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70251-6"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.3201\/eid1206.051297"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61016-2"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-017-0587-4"},{"key":"CIT0034","unstructured":"Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0 through 18 years\u2013United States, 2017. [cited 2017 July 18]. Available from: https:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/child\/0-18yrs-child-combined-schedule.pdf"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2013.05.009"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6429a3"},{"key":"CIT0037","first-page":"1","volume":"60","author":"National Center for Immunization and Respiratory Diseases","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"CIT0038","first-page":"620","volume":"63","author":"Stokley S","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piv039"},{"key":"CIT0040","unstructured":"US Food and Drug Administration. Summary basis for regulatory action. [cited 2017 Oct 23]. Available from: http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM424125.pdf"},{"key":"CIT0041","unstructured":"Australian Government Department of Health TGA. Prescription medicines: Registration of new chemical entities in Australia. [cited 2017 Oct 23]. Available from: https:\/\/www.tga.gov.au\/prescription-medicines-registration-new-chemical-entities-australia"},{"key":"CIT0042","unstructured":"Product monograph: Trumenba. [cited 2017 Oct 23]. Available from: https:\/\/pdf.hres.ca\/dpd_pm\/00041515.PDF"},{"key":"CIT0043","unstructured":"European Medicines Agency. Bexsero EPAR summary for the public. [cited 2017 Mar 27]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/human\/002333\/WC500137857.pdf"},{"key":"CIT0044","unstructured":"US Food and Drug Administration. Summary basis for regulatory action: Bexsero. [cited 2017 Feb 2]. Available from: http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM434748.pdf"},{"key":"CIT0045","unstructured":"Bexsero\u00ae (meningococcal group B vaccine). Full Prescribing Information, Novartis Vaccines and Diagnostics, Inc, Cambridge, MA, USA, 2015."},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0155-7"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.3.1568-1573.2001"},{"key":"CIT0048","unstructured":"US Food and Drug Administration. Summary basis for regulatory action - Menveo (August 1, 2013). [cited 2017 Aug 16]. Available from: https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM365527.pdf"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.065"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00299-7"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31818a0237"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-012-1924-0"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.16.1520"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.6.3140"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/22.22.4673"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00036-18"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.01.021"},{"key":"CIT0058","unstructured":"PubMLST. Query fHbp sequences - Neisseria profile\/sequence definitions database. [cited 2018 Mar 8]. Available from: https:\/\/pubmlst.org\/bigsdb?db=pubmlst_neisseria_seqdef&page=alleleQuery&locus=%2527fHbp&submit=1"},{"key":"CIT0059","unstructured":"European Medicines Agency. Assessment report: Trumenba. [cited 2017 July 7]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/004051\/WC500228997.pdf"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.07.065"},{"key":"CIT0061","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/INF.0b013e31826327e4","volume":"31","author":"Marshall HS","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31827b0d24"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70087-7"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.4161\/hv.19983"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piv064"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001072"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061760"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001124"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1086\/600141"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.12.016"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.01.044"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614474"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.4161\/hv.25505"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.02.025"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-116"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16725-1"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1002\/3527608508.ch16"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30314-0"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6619a6"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.01.066"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00121-17"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001399"},{"key":"CIT0083","doi-asserted-by":"crossref","unstructured":"McNamara L Meningococcal carriage evaluation in response to a serogroup B meningococcal disease outbreak and mass vaccination campaign at a university \u2014 Oregon, 2015\u20132016. [cited 2017 Oct 2]. Available from: http:\/\/www.oregon.gov\/oha\/PH\/PREVENTIONWELLNESS\/VACCINESIMMUNIZATION\/IMMUNIZATIONPARTNERSHIPS\/COALITIONS\/Documents\/FluSumMCNAMARACarriageStudy.pdf","DOI":"10.1093\/ofid\/ofw172.585"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1080\/07448481.2017.1285772"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.3201\/eid2305.161870"},{"key":"CIT0086","unstructured":"Rutgers University Student Health. General information: serogroup B meningococcal disease (\u201cMeningitis B\u201d). [cited 2018 Mar 13]. Available from: http:\/\/health.rutgers.edu\/meningitis\/"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix446"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix091"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.3201\/eid2306.161768"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)00037-N"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.04.015"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.08.006"},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1514866"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-4015"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7954-11-17"},{"key":"CIT0096","volume-title":"Presented at: European Society for Paediatric Infectious Diseases","author":"Harris S","year":"2017"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6619a6"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1115C"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000822"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.0.14564"},{"key":"CIT0101","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-595"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2018.1483726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T09:31:03Z","timestamp":1661419863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2018.1483726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,3]]},"references-count":101,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6,3]]}},"alternative-id":["10.1080\/14760584.2018.1483726"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2018.1483726","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-12-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}